v3.23.1
Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Income Statement [Abstract]    
REVENUES
OPERATING EXPENSES    
Compensation and related expenses 332,316 756,399
Professional fees 459,134 639,405
General and administrative 68,000 119,468
Research and development expenses 206,544 254,837
Total Operating Expenses 1,065,996 1,770,109
LOSS FROM OPERATIONS (1,065,996) (1,770,109)
OTHER INCOME (EXPENSE)    
Financing costs including interest (43,118) (18,137)
Inducement interest (397,928)
Total Other Expense, net (441,046) (18,137)
Loss from operations before income taxes (1,507,042) (1,788,246)
INCOME TAXES
NET LOSS (1,507,042) (1,788,246)
Series A preferred contractual dividends (7,200) (7,202)
Series B preferred contractual dividends (37,207) (37,206)
Deemed dividends from Series A and B conversion price reduction (265,080)
Deemed dividend on warrant modification (282,309) (41,225)
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS $ (2,098,838) $ (1,873,879)
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS: BASIC AND DILUTED: $ (0.90) $ (1.12)
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING: BASIC AND DILUTED 2,330,690 1,668,677